Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study (Q81044910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Mario Rango

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Cristiana Bonifati

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cerebral Blood Flow & Metabolism

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

283-290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

Visual dysfunction in patients with mitochondrial myopathies

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Visual dysfunction in patients with mitochondrial myopathies. II. Contrast sensitivity function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Commentary on "Alpha-synuclein and mitochondria: a tangled skein".

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Behavioral and neurochemical effects induced by subchronic exposure to 40 ppm toluene in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Dynamic mapping of the human visual cortex by high-speed magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Neuroleptic medications inhibit complex I of the electron transport chain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Comparison of environmental and genetic factors for Parkinson's disease between Chinese and Caucasians.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Progressive worsening of spatial and chromatic processing deficits in Parkinson disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Cortical glucose metabolism in Parkinson's disease without dementia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

ATP and brain function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Nonoxidative glucose consumption during focal physiologic neural activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Point mutations of mitochondrial genome in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Effect of photic stimulation on energy metabolism in the human brain measured by 31P-MR spectroscopy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Activation-induced resetting of cerebral oxygen and glucose uptake in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Quantitation of a mitochondrial DNA deletion in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Mitochondria and ageing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: a phosphorus magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Energetics of 3.5 s neural activation in humans: a 31P MR spectroscopy study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Brain pH in head injury: an image-guided 31P magnetic resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Central nervous system trans‐synaptic effects of acute axonal injury: a 1h magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Effect of photic stimulation on human visual cortex lactate and phosphates using 1H and 31P magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Mitochondria in the etiology and pathogenesis of parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Mitochondrial oxidative phosphorylation defects in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Origin and functional consequences of the complex I defect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Mitochondrial genetics: a paradigm for aging and degenerative diseases?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600192

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094320%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference